{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:10:46Z","timestamp":1768281046430,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.mehy.2010.10.034","type":"journal-article","created":{"date-parts":[[2010,11,14]],"date-time":"2010-11-14T09:31:10Z","timestamp":1289727070000},"page":"339-342","source":"Crossref","is-referenced-by-count":12,"title":["Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity"],"prefix":"10.1016","volume":"76","author":[{"given":"Xiran","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Xianmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2010.10.034_b0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sder.2009.04.008","article-title":"Vitiligo update","volume":"28","author":"Halder","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.mehy.2010.10.034_b0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0190-9622(96)90112-7","article-title":"Psychologic effects of vitiligo: a critical incident analysis","volume":"35","author":"Kent","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-148X.2008.00528.x","article-title":"Update on skin repigmentation therapies in vitiligo","volume":"22","author":"Falabella","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.mehy.2010.10.034_b0020","first-page":"160","article-title":"Clinical practice Vitiligo","volume":"360","author":"Taeb","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2010.10.034_b0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1600-0625.2008.00826.x","article-title":"Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff","volume":"18","author":"Boissy","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0030","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2010.10.034_b0035","first-page":"137","article-title":"B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases","volume":"110","author":"Krivosikova","year":"2009","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.mehy.2010.10.034_b0040","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ni0901-764","article-title":"Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity","volume":"2","author":"Lipsky","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2010.10.034_b0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-065X.2008.00646.x","article-title":"B-lymphocyte contributions to human autoimmune disease","volume":"223","author":"Yanaba","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.mehy.2010.10.034_b0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.smim.2006.07.003","article-title":"Travelling with the BAFF\/BLyS family: are we there yet?","volume":"18","author":"Mackay","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.mehy.2010.10.034_b0055","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.4049\/jimmunol.167.11.6225","article-title":"T cell costimulation by the TNF ligand BAFF","volume":"167","author":"Huard","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2010.10.034_b0060","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/1523-1747.ep12522891","article-title":"Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation","volume":"81","author":"Naughton","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0065","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/1523-1747.ep12476728","article-title":"Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo","volume":"100","author":"Yu","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0070","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0190-9622(86)70260-0","article-title":"Correlation between vitiligo antibodies and extent of depigmentation in vitiligo","volume":"15","author":"Naughton","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0075","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0080","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients\u2019 sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0085","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","article-title":"In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo","volume":"105","author":"Gilhar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2007.07.012","article-title":"Apoptosis of melanocytes in vitiligo results from antibody penetration","volume":"29","author":"Ruiz-Arg\u00fcelles","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.mehy.2010.10.034_b0095","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2010.10.034_b0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.1711700209","article-title":"An immunohistological study of cutaneous lymphocytes in vitiligo","volume":"170","author":"Badri","year":"1993","journal-title":"J Pathol"},{"key":"10.1016\/j.mehy.2010.10.034_b0115","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site","volume":"80","author":"van den Wijngaard","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.mehy.2010.10.034_b0120","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0125","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","article-title":"Autoimmunity as an aetiological factor in vitiligo","volume":"21","author":"Rezaei","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mehy.2010.10.034_b0130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-4362.1993.tb04269.x","article-title":"Peripheral blood lymphocyte imbalance in Koreans with active vitiligo","volume":"32","author":"Hann","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0135","first-page":"47","article-title":"Characterization of lymphocyte surface markers in patients with vitiligo","volume":"8","author":"Salmasi","year":"2003","journal-title":"Russ J Immunol"},{"key":"10.1016\/j.mehy.2010.10.034_b0140","doi-asserted-by":"crossref","first-page":"20882","DOI":"10.1073\/pnas.0709205105","article-title":"Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice","volume":"104","author":"Bouaziz","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2010.10.034_b0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ni.1802","article-title":"Autoimmunity: increasing suspects in the CD4+ T cell lineup","volume":"11","author":"Palmer","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2010.10.034_b0150","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.4049\/jimmunol.175.5.2814","article-title":"B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells","volume":"175","author":"Yang","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2010.10.034_b0155","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4049\/jimmunol.174.9.5537","article-title":"BAFF augments certain Th1-associated inflammatory responses","volume":"174","author":"Sutherland","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2010.10.034_b0160","doi-asserted-by":"crossref","first-page":"20878","DOI":"10.1073\/pnas.0709205105","article-title":"Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice","volume":"104","author":"Bouaziz","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2010.10.034_b0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archderm.138.1.29","article-title":"Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples","volume":"138","author":"Correia","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1346-8138.1997.tb02292.x","article-title":"Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo","volume":"24","author":"Honda","year":"1997","journal-title":"J Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0923-1811(98)00070-X","article-title":"Serum concentration of the soluble interleukin-2 receptor in vitiligo patients","volume":"19","author":"Yeo","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.mehy.2010.10.034_b0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","article-title":"Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo","volume":"21","author":"Caixia","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.mehy.2010.10.034_b0185","first-page":"1085","article-title":"Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients","volume":"26","author":"Zailaie","year":"2005","journal-title":"Saudi Med J"},{"key":"10.1016\/j.mehy.2010.10.034_b0190","first-page":"172","article-title":"Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity","volume":"215","author":"Kurts","year":"1998","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.mehy.2010.10.034_b0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2567.2008.02833.x","article-title":"Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses","volume":"125","author":"Lee","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.mehy.2010.10.034_b0200","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.4049\/jimmunol.0903009","article-title":"B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice","volume":"184","author":"DiLillo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2010.10.034_b0205","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaut.2008.04.001","article-title":"A new role for an old player: do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of type 1 diabetes?","volume":"31","author":"Mari\u00f1o","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.mehy.2010.10.034_b0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/08916930701773941","article-title":"Expression of AIRE in thymocytes and peripheral lymphocytes","volume":"41","author":"Suzuki","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.mehy.2010.10.034_b0215","doi-asserted-by":"crossref","first-page":"18466","DOI":"10.1073\/pnas.0808205105","article-title":"AIRE regulates T-cell-independent B-cell responses through BAFF","volume":"105","author":"Lindh","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2010.10.034_b0220","first-page":"591","article-title":"The autoimmune regulator gene (AIRE) is strongly associated with vitiligo","volume":"159","author":"Tazi-Ahnini","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mehy.2010.10.034_b0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/978-0-387-89520-8_4","article-title":"Targeting of BAFF and APRIL for autoimmunity and oncology","volume":"647","author":"Ryan","year":"2009","journal-title":"Adv Exp Med Biol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710004470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710004470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T08:32:26Z","timestamp":1559809946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987710004470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0306987710004470"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2010.10.034","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}